Template:Oral hypoglycemics/ja: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
Created page with "{{Navbox with collapsible groups | name = Oral hypoglycemics and insulin analogs/ja | title = 経口糖尿病治療薬、インスリン製剤およびインスリンアナログ製剤、糖尿病に用いられるその他の薬剤（A10） | state = {{{state<includeonly>|expanded</includeonly>}}} | listclass = hlist | group1 = インスリン/insulin analog/ja|イ..."
 
Tag: Redirect target changed
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{Navbox with collapsible groups
#REDIRECT [[Template:Oral hypoglycemics and insulin analogs/ja]]
| name = Oral hypoglycemics and insulin analogs/ja
| title = 経口[[diabetes medication/ja|糖尿病治療薬]]、[[insulin/ja|インスリン]]製剤および[[insulin analog/ja|インスリンアナログ]]製剤、糖尿病に用いられるその他の薬剤（[[ATC codeA10/ja|A10]]）
| state = {{{state<includeonly>|expanded</includeonly>}}}
| listclass = hlist
 
| group1 = [[Insulin/ja|インスリン]]/[[insulin analog/ja|インスリンアナログ]]
| list1 = {{Navbox|child
 
    | group1 = ''超速効型''
    | list1=
* [[Insulin aspart/ja]]
* [[Insulin glulisine/ja]]
* [[Insulin lispro/ja]]
   
    | group2 = ''速効型''
    | list2 =
* [[Regular insulin/ja]]<sup>#</sup>
 
    | group3 = ''長時間作用型''
    | list3 =
* [[Insulin detemir/ja]]<sup>#</sup>
* [[Insulin glargine/ja]]<sup>#</sup> ([[Insulin glargine/lixisenatide/ja|+リキセナチド]])
* [[NPH insulin/ja]]
* [[Lente insulin/ja]]<sup>‡</sup>
* [[Ultralente insulin/ja]]<sup>‡</sup>
 
    | group4 = ''超長時間作業型''
    | list4 =
* [[Insulin degludec/ja]]<sup>#</sup> ([[Insulin degludec/insulin aspart/ja|+インスリンアスパルト]], [[Insulin degludec/liraglutide/ja|+リラグルチド]])
* [[Insulin icodec/ja]]<sup>†</sup> ([[Insulin icodec/semaglutide/ja|+セマグルチド]])
 
    | group5 = ''[[Inhalable insulin/ja|吸入可能]]''
    | list5 =
* Exubera<sup>‡</sup>
* Afrezza
  }}
{{PharmNavFootnote}}
 
| group2 = 非インスリン
| list2= {{navbox|child|
  | group1 = [[Anti-diabetic medication#Sensitizers/ja|インスリン感作薬]]
  | list1 = {{Navbox|child
 
    | group1 = [[Biguanide/ja]]
    | list1 =
* [[Buformin/ja]]<sup>‡</sup>
* [[Metformin/ja]]<sup>#</sup>
* [[Phenformin/ja]]<sup>‡</sup>
 
    | group2 = [[Thiazolidinedione/ja|TZD]]/"グリタゾン" ([[PPAR agonist/ja|PPAR]])
    | list2 =
* [[Ciglitazone/ja]]<sup>§</sup>
* [[Darglitazone/ja]]<sup>§</sup>
* [[Englitazone/ja]]<sup>§</sup>
* [[Lobeglitazone/ja]]
* [[Netoglitazone/ja]]<sup>§</sup>
* [[Pioglitazone/ja]]
* [[Rivoglitazone/ja]]<sup>†</sup>
* [[Rosiglitazone/ja]]
* [[Troglitazone/ja]]<sup>‡</sup>
 
    | group3 = [[PPAR agonist/ja#Dual PPAR agonists|デュアルPPAR作動薬]]
    | list3 =
* [[Aleglitazar/ja]]<sup>†</sup>
* [[Muraglitazar/ja]]<sup>§</sup>
* [[Saroglitazar/ja]]
* [[Tesaglitazar/ja]]<sup>§</sup>
 
 
  | group4 = [[Amylin/ja]]アナログ と [[DACRA/ja|DACRA]]
  | list4 =
* [[Cagrilintide/ja]]<sup>§</sup>
* [[Pramlintide/ja]]
  }}
 
  | group2 = [[Anti-diabetic medication/ja#Secretagogues|セクレタゴーグ]]
  | list2 = {{Navbox|child
 
    | group1 = [[ATP-sensitive potassium channel/ja|K<sup>+</sup><sub>ATP</sub>]]
    | list1 = {{Navbox|child
      | evenodd = swap
 
      | group1 = [[Sulfonylurea/ja]]
      | list1 =
* ''第一世代'': [[Acetohexamide/ja]]
* [[Carbutamide/ja]]
* [[Chlorpropamide/ja]]
* [[Glycyclamide/ja]]
* [[Metahexamide/ja]]
* [[Tolazamide/ja]]
* [[Tolbutamide/ja]]
 
* ''第二世代'': [[Glibenclamide/ja|グリベンクラミド（グリブリド）]]
* [[Glibornuride/ja]]
* [[Glicaramide/ja]]
* [[Gliclazide/ja]]<sup>#</sup>
* [[Glimepiride/ja]]
* [[Glipizide/ja]]
* [[Gliquidone/ja]]
* [[Glisoxepide/ja]]
* [[Glyclopyramide/ja]]
 
      | group2 = [[Meglitinide/ja]]/"グリニド系"
      | list2 =
* [[Mitiglinide/ja]]
* [[Nateglinide/ja]]
* [[Repaglinide/ja]]
 
    }}
 
    | group2 = [[Glucagon-like peptide-1 receptor agonist/ja|GLP-1受容体作動薬]]
    | list2 =
* [[Albiglutide/ja]]<sup>‡</sup>
* [[Danuglipron/ja]]<sup>†</sup>
* [[Dulaglutide/ja]]
* [[Exenatide/ja]]
* [[Liraglutide/ja]]
* [[Lixisenatide/ja]]
* [[Orforglipron/ja]]<sup>§</sup>
* [[Semaglutide/ja]]
* [[Taspoglutide/ja]]<sup>†</sup>
{{navbox|child|
group1=[[GLP1 poly-agonist peptides/ja]]
|list1=
* [[Mazdutide/ja]] (GLP-1/[[Glucagon receptor/ja|GCGR]])
* [[Retatrutide/ja]]<sup>§</sup> (GLP-1/GIP/GCGR)
* [[Tirzepatide/ja]] (GLP-1/GIP)
}}
    | group3 = [[Dipeptidyl peptidase-4 inhibitor/ja|DPP-4 阻害薬]]/"グリプチン"
    | list3 =
* [[Alogliptin/ja]]
* [[Anagliptin/ja]]
* [[Evogliptin/ja]]
* [[Garvagliptin/ja]]
* [[Gemigliptin/ja]]
* [[Gosogliptin/ja]]
* [[Linagliptin/ja]]
* [[Melogliptin/ja]]
* [[Omarigliptin/ja]]
* [[Saxagliptin/ja]]
* [[Sitagliptin/ja]]
* [[Teneligliptin/ja]]
* [[Trelagliptin/ja]]
* [[Vildagliptin/ja]]
}}
  |group3 = その他
  |list3 = {{navbox|child
  | group1 = [[Aldose reductase inhibitor/ja]]
  | list1 =
* [[Epalrestat/ja]]
* [[Fidarestat/ja]]<sup>§</sup>
* [[Ranirestat/ja]]<sup>†</sup>
* [[Tolrestat/ja]]<sup>‡</sup>
* [[Zenarestat/ja]]<sup>§</sup>
 
  | group2 = [[Alpha-glucosidase inhibitor/ja]]
  | list2 =
* [[Acarbose/ja]]
* [[Miglitol/ja]]
* [[Voglibose/ja]]
 
  | group4 = [[Gliflozin/ja|SGLT2 阻害薬]]/"グリフロジン"
  | list4 =
* [[Canagliflozin/ja]]
* [[Dapagliflozin/ja]]
* [[Empagliflozin/ja]]<sup>#</sup>
* [[Ertugliflozin/ja]]
* [[Ipragliflozin/ja]]
* [[Luseogliflozin/ja]]
* [[Remogliflozin etabonate/ja|レモグリフロジン]]<sup>§</sup>
* [[Sergliflozin etabonate/ja|セルグリフロジン]]<sup>§</sup>
* [[Sotagliflozin/ja]]
* [[Tofogliflozin/ja]]<sup>†</sup>
* [[Velagliflozin/ja]]
 
  | group5 = その他
  | list5 =
* [[Benfluorex/ja]]<sup>‡</sup>
* [[Bromocriptine/ja]]
* [[Imeglimin/ja]]
}}
  |group4 = [[Combination drug/ja|配合薬]]
  |list4 = {{navbox|child
    |list1 =
* [[Alogliptin/metformin/ja]]
* [[Canagliflozin/metformin/ja]]
* [[Cagrilintide/semaglutide/ja]]<sup>§</sup>
* [[Dapagliflozin/metformin/ja]]
* [[Dapagliflozin/saxagliptin/ja]]
* [[Dapagliflozin/saxagliptin/metformin/ja]]
* [[Empagliflozin/linagliptin/ja]]
* [[Empagliflozin/metformin/ja]]
* [[Gemigliptin/rosuvastatin/ja]]
* [[Glibenclamide/metformin/ja|グリベンクラミド(グリブリド)/メトホルミン]]
* [[Glimepiride/rosiglitazone/ja]]
* [[Linagliptin/metformin/ja]]
* [[Metformin/acarbose/ja]]
* [[Metformin/ertugliflozin/ja]]
* [[Metformin/evogliptin/ja]]
* [[Metformin/gemigliptin/ja]]
* [[Metformin/repaglinide/ja]]
* [[Metformin/sulfonylureas/ja]]
* [[Metformin/teneligliptin/ja]]
* [[Phenformin/sulfonylureas/ja]]
* [[Pioglitazone/alogliptin/ja]]
* [[Pioglitazone/glimepiride/ja]]
* [[Pioglitazone/metformin/ja]]
* [[Pioglitazone/sitagliptin/ja]]
* [[Rosiglitazone/metformin/ja]]
* [[Saxagliptin/metformin/ja]]
* [[Sitagliptin/dapagliflozin/ja]]
* [[Sitagliptin/ertugliflozin/ja]]
* [[Sitagliptin/metformin/ja]]
* [[Simvastatin/sitagliptin/ja|シタグリプチン/シンバスタチン]]
* [[Vildagliptin/metformin/ja]]
 
}}
}}
{{PharmNavFootnote}}
}}
<noinclude>
{{Collapsible option}}
[[Category:Drug templates by ATC]]
</noinclude>

Latest revision as of 15:58, 5 February 2024

Redirect to:

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Template:Oral_hypoglycemics/ja&oldid=110904"